Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

White Papers
Optimizing the Supply Chain through Data Transparency and Integration
This paper addresses the importance of the supply chain on overall health care costs and how transparent data can lead to a best practice sup
Case Studies
Leading Practice: Reduction or Elimination of CAUTI - Nexera, Inc.
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of HAPU - Nexera
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Advisory
CMS Releases Final Rules for CY 2011 Hospital Outpatient/ASC Payment System, Physician Fee Schedule and Home Health Payment System
An overview of the Centers for Medicare & Medicaid Services' three final rules for calendar year 2011 the outpatient prospective payment
Advisory
CMS Releases Proposed Rule for Hospital Value-Based Purchasing Program
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Advisory
Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data
Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data